Pnc Financial Services Group, Inc. Arcutis Biotherapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 8,271 shares of ARQT stock, worth $94,289. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,271
Previous 9,919
16.61%
Holding current value
$94,289
Previous $92,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ARQT
# of Institutions
207Shares Held
129MCall Options Held
738KPut Options Held
82K-
Jennison Associates LLC12.3MShares$141 Million0.11% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$125 Million2.84% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.7MShares$122 Million3.92% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$100 Million4.4% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$98.3 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $686M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...